PT Bank Rakyat Indonesia (Persero) Tbk (IDX:BBRI)

Revance Therapeutics Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	557,177,994	614,648,423	863,641,192	747,283,828	616,678,422	511,222,595
Market Cap Growth	-18.77%	-28.83%	15.57%	21.18%	20.63%	-5.06%
Last Close Price	3700.00	3856.24	4970.78	4036.05	3229.89	3121.76
PE Ratio	9.84	10.22	14.37	14.60	19.85	27.40
PS Ratio	4.16	4.63	6.30	5.93	5.53	5.54
PB Ratio	1.73	1.90	2.73	2.46	2.11	2.23
P/FCF Ratio	34.51	149.70	-	-	-	-
P/OCF Ratio	20.35	42.56	-	-	-	-
Debt / Equity Ratio	0.63	0.59	0.55	0.53	0.54	0.79
Debt / FCF Ratio	12.50	46.60	-	-	-	-
Return on Equity (ROE)	18.07%	18.96%	19.50%	17.27%	11.80%	8.52%
Return on Assets (ROA)	2.80%	3.06%	3.16%	2.90%	1.87%	1.23%
Earnings Yield	10.18%	9.79%	6.96%	6.85%	5.04%	3.65%
FCF Yield	2.90%	0.67%	-7.67%	-10.46%	-2.68%	-13.97%
Dividend Yield	9.26%	8.91%	6.42%	7.14%	5.39%	-
Payout Ratio	91.19%	79.96%	72.37%	51.61%	39.03%	110.55%
Buyback Yield / Dilution	0.13%	0.10%	0.33%	-15.96%	-5.89%	-0.80%
Total Shareholder Return	9.39%	9.01%	6.74%	-8.82%	-0.49%	-0.80%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.